New appointment at Wyeth
This article was originally published in Scrip
Executive Summary
Wyeth (US) has appointed Daniel McIntyrevice-president of corporate communications. He will be responsible for internal and external communications for the company and its three major divisions – pharmaceuticals, consumer healthcare and animal health. He was previously managing director of the healthcare practice of Fleishman-Hillard International Communications. Mr McIntyre also held senior level communications and public policy positions at Pharmacia, Bayer, Bristol-Myers Squibb and Roche.
You may also be interested in...
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.
Report Finds Digital Diabetes Tools Deliver No ‘Meaningful Clinical Benefits'
A new report from health economics group the Peterson Health Technology Institute found that apps to help patients manage their blood sugar levels delivered few of the promised benefits. However, a digital therapeutics industry association says PHTI’s research cast too narrow a net.
Merck’s Winrevair Well Positioned To Benefit From Medicare Part D Redesign
Significant cost sharing reductions under the redesign will enhance uptake of the pulmonary arterial hypertension drug. The trade-off is a 20% mandatory price discount in the catastrophic phase.